ISME J • 2021.03.10
Wang Y., Lu J., Zhang S. et al.
Front. Microbiol. • 2021.01.26
Kumar M., Kumar Sarma D., Shubham S., et al.
- Antibiotic stewardship, New antibiotics and alternatives
- International
- Alternative therapies, Antimicrobial Peptides, CRISPR-Cas, Fecal Microbiota Transplant, Hemofiltration Devices, Immunotherapeutic, Nanoantibiotics, One Health, Phage Therapies, Postbiotics, Probiotics, Quorum-Sensing Inhibitors, Synbiotics
Lancet Infect Dis • 2019.10.03
Chang J., Xu S., Zhu S., et al.
Antibiotics • 2021.03.04
Ngassam Tchamba C., Duprez J.N, Lucas P., et al.
International Journal of Health and Clinical Research • 2021.03.09
Deb S., Choudhury K., Sarkar S., et al.
Microb Genom. • 2019.09.01
Branger C., Ledda A., Billard-Pomares T., et al.
Lancet Infect Dis • 2019.09.25
Kollef M.H., Nová?ek M., Kivistik Ü., et al.
- Clinical trial
- International
- Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia
Lancet • 2019.06.22
Ross J.D.C., Brittain C., Cole M., Dewsnap C., Harding J., Hepburn T., Jackson L., Keogh M., Lawrence T., Montgomery A.A., Roberts T.E., Sprange K., Tan W., Thandi S., White J., Wilson J., Duley L., G-ToG trial team
- Clinical trial
- International
- Azithromycin, Ceftriaxone, Clinical trial, Gentamicins, Gonorrhea
Antibiotics • 2021.04.13
Raza S., Matuła K., Karoń S., et al.
European Journal of Medicinal Chemistry • 2019.03.01
Olleik H., Yahiaoui S., Roulier B., et al.